Fosnetupitant

Major

Fosnetupitant Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Fosnetupitant Abametapir Explained Increased exposure of CYP3A4 substrate Details Fosnetupitant Omeprazole Gastrobim Explained Increased exposure of CYP3A4 substrate Details Fosnetupitant Buprenorphine Belbuca Explained Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Fosnetupitant Colchicine Colcrys Explained Increased colchicine exposure and an increased risk of fatal toxicity Details Fosnetupitant Simvastatin Flolipid Explained Increased exposure of CYP3A4 substrate Details Fosnetupitant Acalabrutinib Calquence Increased acalabrutinib exposure and increased risk of toxicity Details Fosnetupitant Aripiprazole Injection Abilify Increased exposure of CYP3A4 substrate Details Fosnetupitant Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Fosnetupitant Atorvastatin Atorvaliq Increased exposure of CYP3A4 substrate Details Fosnetupitant Cariprazine Vraylar Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Fosnetupitant Alfuzosin UroXatral Increased exposure of CYP3A4 substrate Details Fosnetupitant Amlodipine Amvaz® Increased exposure of CYP3A4 substrate Details Fosnetupitant Avanafil Stendra Increased exposure of CYP3A4 substrate Details Fosnetupitant Axitinib Inlyta Increased exposure of CYP3A4 substrate Details Fosnetupitant Bedaquiline Sirturo Increased bedaquiline exposure Details Fosnetupitant Bosutinib Bosulif Increased exposure of CYP3A4 substrate Details Fosnetupitant Brexpiprazole Rexulti Increased brexpiprazole exposure Details Fosnetupitant Brigatinib Alunbrig Increased brigatinib exposure Details Fosnetupitant Budesonide Entocort Increased exposure of CYP3A4 substrate Details Fosnetupitant Budesonide Nasal Spray Rhinocort Increased exposure of CYP3A4 substrate Details Fosnetupitant Budesonide Oral Inhalation Pulmicort Increased exposure of CYP3A4 substrate Details Fosnetupitant Cabozantinib Cabometyx Increased exposure of CYP3A4 substrate Details Fosnetupitant Cabozantinib (Thyroid Cancer) Cabometyx Increased exposure of CYP3A4 substrate Details Fosnetupitant Cobimetinib Cotellic Increased exposure of CYP3A4 substrate Details Fosnetupitant Cyclosporine Injection Atopica Increased exposure of CYP3A4 substrate Details Fosnetupitant Cyclosporine Ophthalmic Cequa Increased exposure of CYP3A4 substrate Details Fosnetupitant Dasatinib Phyrago Increased exposure of CYP3A4 substrate Details Fosnetupitant Diazepam Nasal Spray Valtoco Increased exposure of CYP3A4 substrate Details Fosnetupitant Diazepam Rectal Diastat Increased exposure of CYP3A4 substrate Details Fosnetupitant Dihydroergotamine Injection DHE-45® Injection Increased exposure of CYP3A4 substrate Details Fosnetupitant Dihydroergotamine Nasal Spray Migranal Increased exposure of CYP3A4 substrate Details Fosnetupitant Docetaxel Beizray Increased exposure to chemotherapy agent and increased risk of side effects Details Fosnetupitant Docetaxel Injection Beizray Increased exposure to chemotherapy agent and increased risk of side effects Details Fosnetupitant Dofetilide Tikosyn Increased exposure of CYP3A4 substrate Details Fosnetupitant Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Fosnetupitant Elacestrant Orserdu Increased elacestrant exposure and an increased risk of elacestrant-related adverse effects Details Fosnetupitant Encorafenib Braftovi Increased encorafenib exposure and an increased risk of encorafenib-related adverse events Details Fosnetupitant Entrectinib Rozlytrek Increased entrectinib exposure and an increased frequency or severity of adverse reactions Details Fosnetupitant Estradiol Delestrogen Increased exposure of CYP3A4 substrate Details